Vol 8, No 4 (2023)
Original article
Published online: 2023-10-12

open access

Page views 524
Article views/downloads 331
Get Citation

Connect on Social Media

Connect on Social Media

Rh negativity seems to predispose to a milder COVID-19 course

Monika Paskudzka12, Aleksandra Kumorek3, Aleksandra Kijak3, Marcin Śmiarowski3, Dagmara Kogut2, Milena Małecka-Giełdowska12, Olga Ciepiela12
Medical Research Journal 2023;8(4):269-276.

Abstract

Introduction: Infection with the SARS-CoV-2 virus can lead to the development of COVID-19. Currently, more than 700 million people worldwide have been diagnosed with COVID-19, of which nearly 7 million have died from the severe course of the disease. Recent reports suggest that patients with blood group A are most at risk of developing COVID-19, and people with natural anti-A antibodies (especially those with blood type 0) have a milder course of the disease. This study aimed to assess the humoral response to infection with SARS-CoV-2 depending on the patient’s blood type.

Material and methods:
The study group consisted of 147 patients with confirmed previous COVID-19 (convalescents) and 147 individuals who declared no previous infection with SARS-CoV-2. All enrolled subjects were blood donors registered at Regional Blood Center. The concentration of SARS-CoV-2 anti-nucleocapsid antibodies was determined in the serum of the patients using the Elecsys Anti-SARS-CoV-2 test. The blood group was determined by a manual method using anti-A, anti-B, and anti-D monoclonal sera and A, B, and 0 standard red blood cells (RBC).

Results and conclusions: Based on anti-SARS-CoV-2 detection 68 people who denied contact with SARS-CoV-2 had previous asymptomatic infection. Blood type distribution differed between the asymptomatic convalescents and the declared convalescents, p = 0.0013. People with Arh–, BRh+, BRh–, and 0Rh– blood type were more often asymptomatically infected. Moreover, the Rh- subjects more often didn’t know about the previous infection than those with Rh+, p = 0.0012. It seems that subjects with Rh– blood type have a significantly milder course of disease than Rh+.

Article available in PDF format

View PDF Download PDF file

References

  1. Raport zakażeń koronawirusem (SARS-CoV-2) - Koronawirus: informacje i zalecenia- PortalGov.pl. https://www.gov.pl/web/koronawirus/wykaz-zarazen-koronawirusem-sars-cov-2 (14.07.2023).
  2. Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol. 2020; 92(4): 424–432.
  3. Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev. 2021; 34(3).
  4. Cevik M, Bamford CGG, Ho A. COVID-19 pandemic — a focused review for clinicians. Clin Microbiol Infect. 2020; 26(7): 842–847.
  5. Zhang JJ, Dong X, Liu GH, et al. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023; 64(1): 90–107.
  6. Radzikowska U, Ding M, Tan Ge, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020; 75(11): 2829–2845.
  7. Davies NG, Klepac P, Liu Y, et al. CMMID COVID-19 working group. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020; 26(8): 1205–1211.
  8. Shakoor H, Feehan J, Al Dhaheri AS, et al. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas. 2021; 143: 1–9.
  9. Ellinghaus D, Degenhardt F, Bujanda L, et al. Severe Covid-19 GWAS Group. Genomewide association study of severe COVID-19 with respiratory failure. N Engl J Med. 2020; 383(16): 1522–1534.
  10. Guillon P, Clément M, Sébille V, et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008; 18(12): 1085–1093.
  11. Tamayo-Velasco Á, Peñarrubia-Ponce MJ, Álvarez FJ, et al. ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points. Front Med (Lausanne). 2022; 9: 882477.
  12. Anstee DJ. The relationship between blood groups and disease. Blood. 2010; 115(23): 4635–4643.
  13. Grupy krwi. Dziedziczenie grupy krwi. https://krwiodawcy.org/grupy-krwi (14.07.2023).
  14. Zhao J, Yang Y, Huang H, et al. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility. Clin Infect Dis. 2021; 73(2): 328–331.
  15. Bshaena AM, Almajdoub OH, Alshwesh RA, et al. Association Between ABO Blood Group System and COVID-19 Severity. Am J Clin Pathol. 2022; 158(5): 570–573.
  16. Balaouras G, Eusebi P, Kostoulas P. Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infection. PLoS One. 2022; 17(7): e0271451.
  17. Moslemi C, Saekmose S, Larsen R, et al. A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID-19 susceptibility, severity, and long COVID-19. Transfusion. 2023; 63(1): 47–58.
  18. Sticchi Damiani A, Zizza A, Banchelli F, et al. Seroprevalence COVID Blood Donors Study Group. Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region. Ann Hematol. 2023; 102(10): 2923–2931.
  19. Turhan AB, Icten S, Ayazoglu TA, et al. ABO-Rh Blood Types and Clinical Consequences of COVID-19 Infection. Niger J Clin Pract. 2022; 25(10): 1660–1665.
  20. Arent CO, Padilha AP, Borba LA, et al. ABO Blood Type and Metabolic Markers in COVID-19 Susceptibility and Severity: A Cross-Sectional Study. Metab Syndr Relat Disord. 2023; 21(6): 335–344.
  21. Bhandari P, Durrance RJ, Bhuti P, et al. Analysis of ABO and Rh Blood Type Association With Acute COVID-19 Infection in Hospitalized Patients: A Superficial Association Among a Multitude of Established Confounders. J Clin Med Res. 2020; 12(12): 809–815.
  22. Latz CA, DeCarlo C, Boitano L, et al. Blood type and outcomes in patients with COVID-19. Ann Hematol. 2020; 99(9): 2113–2118.
  23. Ray JG, Schull MJ, Vermeulen MJ, et al. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study. Ann Intern Med. 2021; 174(3): 308–315.
  24. Ijaz S, Cheema AH, Rafiq A, et al. Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility. Expert Rev Hematol. 2023; 16(4): 297–303.
  25. Ergoren MC, Akan G, Guler E, et al. Sex and ABO Blood Differences in SARS-CoV-2 Infection Susceptibility. Glob Med Genet. 2023; 10(1): 22–26.
  26. Khder Mustafa S, Zrar Omar S, Kamal Ahmad K, et al. The association of ABO blood group distribution and clinical characteristics in patients with SARS-CoV-2. J Infect Dev Ctries. 2023; 17(1): 18–22.
  27. Jahrsdörfer B, Groß R, Seidel A, et al. Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors. J Immunol. 2021; 206(11): 2614–2622.
  28. Healy K, Aulin LBS, Freij U, et al. Prevalence of parvovirus B19 viremia among german blood donations and the relationship to ABO and rhesus blood group antigens. J Infect Dis. 2023; 227(10): 1214–1218.
  29. Sugrue JA, Smith M, Posseme C, et al. Milieu Interieur Consortium. Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus. Genes Immun. 2022; 23(2): 93–98.